skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 402  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Middle Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
Material Type:
Article
Add to My Research

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

The New England journal of medicine, 2020-06, Vol.382 (26), p.2493-2503 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1916624 ;PMID: 32579810

Full text available

2
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Material Type:
Article
Add to My Research

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

The New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974

Full text available

3
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Material Type:
Article
Add to My Research

Effects of Allopurinol on the Progression of Chronic Kidney Disease

The New England journal of medicine, 2020-06, Vol.382 (26), p.2504-2513 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1915833 ;PMID: 32579811

Full text available

4
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Material Type:
Article
Add to My Research

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study

Circulation (New York, N.Y.), 2015-05, Vol.131 (20), p.1763-1771 [Peer Reviewed Journal]

2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.114.014536 ;PMID: 25986447

Full text available

5
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Material Type:
Article
Add to My Research

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.811-820 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209213 ;PMID: 27821644 ;CODEN: ARDIAO

Full text available

6
A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout
Material Type:
Article
Add to My Research

A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout

Arthritis & rheumatology (Hoboken, N.J.), 2016-08, Vol.68 (8), p.2027-2034 [Peer Reviewed Journal]

2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. ;2016, American College of Rheumatology ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39684 ;PMID: 26989892

Full text available

7
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Material Type:
Article
Add to My Research

Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk

Clinical journal of the American Society of Nephrology, 2010-08, Vol.5 (8), p.1388-1393 [Peer Reviewed Journal]

Copyright © 2010 by the American Society of Nephrology ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.01580210 ;PMID: 20538833

Full text available

8
Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled study
Material Type:
Article
Add to My Research

Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled study

Clinical endocrinology (Oxford), 2015-10, Vol.83 (4), p.475-482 [Peer Reviewed Journal]

2014 John Wiley & Sons Ltd ;2014 John Wiley & Sons Ltd. ;Copyright © 2015 John Wiley & Sons Ltd ;ISSN: 0300-0664 ;EISSN: 1365-2265 ;DOI: 10.1111/cen.12673 ;PMID: 25400252

Full text available

9
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia
Material Type:
Article
Add to My Research

Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia

Journal of investigative medicine, 2015-12, Vol.63 (8), p.924-929 [Peer Reviewed Journal]

2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 American Federation for Medical Research ;Copyright: 2015 (c) 2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1081-5589 ;EISSN: 1708-8267 ;DOI: 10.1097/JIM.0000000000000242 ;PMID: 26571421

Full text available

10
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial
Material Type:
Article
Add to My Research

Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial

Journal of the American Society of Nephrology, 2024-05, Vol.35 (5), p.594-606 [Peer Reviewed Journal]

EISSN: 1533-3450 ;DOI: 10.1681/ASN.0000000000000326 ;PMID: 38564654

Full text available

11
Vascular Function and Uric Acid-Lowering in Stage 3 CKD
Material Type:
Article
Add to My Research

Vascular Function and Uric Acid-Lowering in Stage 3 CKD

Journal of the American Society of Nephrology, 2017-03, Vol.28 (3), p.943-952 [Peer Reviewed Journal]

Copyright © 2017 by the American Society of Nephrology. ;Copyright © 2017 by the American Society of Nephrology 2017 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2016050521 ;PMID: 27620990

Full text available

12
Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease
Material Type:
Article
Add to My Research

Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease

Journal of the American Society of Nephrology, 2011-07, Vol.22 (7), p.1382-1389 [Peer Reviewed Journal]

Copyright © 2011 by the American Society of Nephrology ;Copyright © 2011 by the American Society of Nephrology 2011 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/ASN.2010111185 ;PMID: 21719783

Full text available

13
Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis

Rheumatology (Oxford, England), 2017-07, Vol.56 (7), p.1144-1153 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/kex065 ;PMID: 28379501

Full text available

14
One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study
Material Type:
Article
Add to My Research

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

Arthritis research & therapy, 2022-04, Vol.24 (1), p.88-88, Article 88 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-022-02772-3 ;PMID: 35443675

Full text available

15
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Material Type:
Article
Add to My Research

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Arthritis research & therapy, 2010-01, Vol.12 (2), p.R63-R63 [Peer Reviewed Journal]

COPYRIGHT 2010 BioMed Central Ltd. ;Copyright ©2010 Becker et al.; licensee BioMed Central Ltd. 2010 Becker et al.; licensee BioMed Central Ltd. ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/ar2978 ;PMID: 20370912

Full text available

16
Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
Material Type:
Article
Add to My Research

Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study

Rheumatology (Oxford, England), 2019-12, Vol.58 (12), p.2122-2129 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/kez189 ;PMID: 31098635

Full text available

17
Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans
Material Type:
Article
Add to My Research

Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans

Clinical journal of the American Society of Nephrology, 2019-12, Vol.14 (12), p.1773-1780 [Peer Reviewed Journal]

Copyright © 2019 by the American Society of Nephrology. ;Copyright © 2019 by the American Society of Nephrology 2019 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.03580319 ;PMID: 31712387

Full text available

18
Impact of allopurinol on risk of myocardial infarction
Material Type:
Article
Add to My Research

Impact of allopurinol on risk of myocardial infarction

Annals of the rheumatic diseases, 2015-05, Vol.74 (5), p.836-842 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-202972 ;PMID: 24395556 ;CODEN: ARDIAO

Full text available

19
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
Material Type:
Article
Add to My Research

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients

Arthritis research & therapy, 2019-03, Vol.21 (1), p.77-77, Article 77 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-019-1860-8 ;PMID: 30894219

Full text available

20
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response
Material Type:
Article
Add to My Research

Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response

Clinical pharmacology and therapeutics, 2015-05, Vol.97 (5), p.518-525 [Peer Reviewed Journal]

2015 American Society for Clinical Pharmacology and Therapeutics ;2015 American Society for Clinical Pharmacology and Therapeutics. ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.89 ;PMID: 25676789

Full text available

Results 1 - 20 of 402  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (364)

Refine My Results

Creation Date 

From To
  1. Before 1977  (43)
  2. 1977 To 1988  (41)
  3. 1989 To 2000  (67)
  4. 2001 To 2013  (120)
  5. After 2013  (133)
  6. More options open sub menu

Language 

  1. English  (392)
  2. Japanese  (55)
  3. Spanish  (7)
  4. Portuguese  (3)
  5. German  (2)
  6. Russian  (1)
  7. French  (1)
  8. Serbian  (1)
  9. Chinese  (1)
  10. More options open sub menu

Searching Remote Databases, Please Wait